EQS-DD: aap Implantate AG: Merval AG, Conversion of shareholder loans into shares not admitted to trading

Comments
Loading...


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

18.02.2025 / 14:47 CET/CEST
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: Merval AG

2. Reason for the notification

a) Position / status
Person closely associated with:
Title: Dr. med.
First name: Nathalie
Last name(s): Krebs
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
aap Implantate AG

b) LEI
39120001TRQTQ01LPP57 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Financial instrument linked to a share or a debt instrument
Description: Shares from capital increase against contribution in kind

b) Nature of the transaction
Conversion of shareholder loans into shares not admitted to trading

c) Price(s) and volume(s)
Price(s) Volume(s)
2.03 EUR 500000 EUR

d) Aggregated information
Price Aggregated volume
2.03 EUR 500000.00 EUR

e) Date of the transaction
14/02/2025; UTC+1

f) Place of the transaction
Outside a trading venue



18.02.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: aap Implantate AG
Lorenzweg 5
12099 Berlin
Germany
Internet: www.aap.de

 
End of News EQS News Service

97059  18.02.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2088095&application_name=news&site_id=benzinga~~~8eb7e128-c3ed-4017-a7d6-2b04218e4b99
Market News and Data brought to you by Benzinga APIs